Opendata, web and dolomites

LiVirIn

3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiVirIn project word cloud

Explore the words cloud of the LiVirIn project. It provides you a very rough idea of what is the project "LiVirIn" about.

disease    train    hepatocyte    inter    replication    interdisciplinary    form    potent    causing    hepatic    immune    independent    cccdna    superior    hampered    lost    transfer    mobility    creation    658    thinker    biophysical    chemotherapy    pharmaceutical    hypothesis    function    liver    boost    delivers    circular    risk    hbv    disseminated    cells    3d    antiviral    eradicate    pscs    stellate    sinusoidal    narrow    nucleus    evaluation    dna    hypothesize    researcher    reactivation    infected    biochemical    peer    engineering    endothelial    expertise    closed    medical    hepatitis    virus    particles    cure    annually    million    organoids    hepatocytes    ing    models    presentations    matrix    enormous    appropriate    biophysics    worldwide    culture    industries    source    lack    strategies    completely    life    encompassing    clinically    inexhaustible    covalently    vitro    vaccination    stable    scientific    tropism    400    academia    safe    model    viral    drugs    maturation    international    animal    conferences    publications    carrier    industry    biology    human    efficacy    people    knowledgeable    stem    mimics    prevented    networking    pluripotent    chronically    hscs    suppression    infection    meetings    an    lsecs    wages   

Project "LiVirIn" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.kuleuven.be/samenwerking/scil/about_us/livirin
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 172˙800.00

Map

 Project objective

An estimated ~400 million people are chronically infected with hepatitis B virus (HBV) infection worldwide, resulting in an estimated $658 million in medical costs and lost wages annually. Although HBV disease can be prevented by vaccination, many people still become infected. Potent and safe drugs are available to eradicate HBV viral particles and clinically ‘cure’ HBV infection. However, during replication HBV delivers a very stable form of viral DNA (covalently closed circular DNA, cccDNA) in the nucleus of the hepatocyte, causing life-long risk of reactivation of HBV infection in case of suppression of the immune system (e.g. chemotherapy). Therefore the pharmaceutical industry is now aiming to develop strategies to eradicate the virus from the infected liver completely. Such studies are hampered by the lack of appropriate in vitro or animal models due to the narrow tropism of HBV for human hepatocytes. The hypothesis of the project is that creation of 3D culture systems encompassing hepatocytes, hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs) derived from an inexhaustible source of cells (human pluripotent stem cells (PSCs)) in a matrix that mimics the biophysical and biochemical features of the liver, will be a superior model for the study of HBV infection and evaluation of the efficacy of antiviral drugs. We also hypothesize that such 3D organoids will improve maturation and function of hepatocytes, HSCs and LSECs. The proposed studies are highly interdisciplinary, merging expertise from biology, to biophysics and engineering, with inter-sector mobility, networking, collaboration and knowledge transfer between academia and industries. The knowledge developed will be disseminated by presentations at consortium meetings, international conferences and in peer publications. All these aspects will train the researcher as independent thinker, more knowledgeable in scientific research which will provide an enormous boost to his carrier.

 Publications

year authors and title journal last update
List of publications.
2016 M. Kumar, G. Rustandi, R. Boon, R. S. Patil, P. Roelandt, C. Verfaillie;
2016 TERMIS - Americas Conference and Exhibition San Diego, CA December 11–14, 2016
published pages: S-1-S-156, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2016.5000.abstracts
Tissue Engineering Part A 22/S1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVIRIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVIRIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MITafterVIT (2020)

Unravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseases

Read More  

INTEGRATE (2018)

An integrated hypothesis for cognitive and positive symptoms in schizophrenia

Read More  

ReproMech (2019)

The Molecular Mechanisms of Cell Fate Reprogramming in Vertebrate Eggs

Read More